Vanguard Capital Management’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCC
MBAM
Vanguard Capital Management's ICCC Position: Q3 2026 in Review
Vanguard Capital Management held its ImmuCell (ICCC) position steady in Q3 2026 at 268,130 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3286.
Vanguard Capital Management first reported a position in ICCC in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.69M in Q2 2026. 31 funds tracked by Wall St. Rank hold ICCC as of Q3 2026.
- Vanguard Capital Management held 268,130 shares of ImmuCell worth $2.63M as of Q3 2026.
- Vanguard Capital Management left its ImmuCell share count unchanged in Q3 2026.
- ImmuCell made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3286 holding.
- Vanguard Capital Management first reported a position in ImmuCell in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's ImmuCell position peaked at $2.69M in Q2 2026.
- 31 funds tracked by Wall St. Rank held ImmuCell as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.